Clinical study assesses triphaladi kwath's effects on HbA1c in diabetes mellitus type II, indicating ayurvedic potential.
Diabetes, a potentially life threatening disorder is considered as an apparent epidemic which is strongly related to life style and economic change”by the WHO.Type-2 diabetes develops as a continuum starting with the fully compensated insulin resistance, normoglycemia and asymptomatic state and then progressing to impaired glucose tolerance with frank diabetes later. The diseases which may develop a series of problems are increasing day by day from corner to corner globally. In Ayurveda Madhumeha chikitsa is described in detail by the Acharyas. The drug Triphaladi kwath described by Acharya Charka in Sutra sthan chap.23rd is selected for the Study. Triphaladi kwath having kaphavata nashak properties, so it is useful in the management of Madhumeha. So this is the aim of the present study to document the “A clinical study of Triphaladi kwath in management of Madhumeha (Diabetes mellitus type II w.s.r.HbA1c)”.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: